Taiwan FDA registration 16e3881c4e343bd2a6aa10d28713298a

Multi-standard nucleic acid detection reagent set for microcrystalline pneumonia pathogens

TW: 微晶肺炎病原體多標的核酸檢測試劑組
Taiwan flagTaiwan·Risk Class 2·BIOFIRE DIAGNOSTICS, LLC·Registered Aug 27, 2020 – Aug 27, 2025Expired
Registration details
Analysis ID
16e3881c4e343bd2a6aa10d28713298a
Customs Code
DHA05603353703
Company information
Manufacturer Country
United States
Product details
Intended Use
This product is a multiplex nucleic acid test used in conjunction with the FilmArray 2.0 or FilmArray Torch System for specimens of sputum type (induced or coughed up sputum, or endotracheal tube aspirate) or bronchoalveolar lavage (BAL) type specimens (BAL or mini-BAL) obtained from individuals with suspected lower respiratory tract infection , simultaneous detection and identification of multiple respiratory viruses and bacterial nucleic acids and selected antibiotic resistance genes.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.3980 呼吸道病毒多標的核酸檢驗試劑
Import Information
Input;; QMS/QSD
Dates and status
Registration Date
Aug 27, 2020
Expiry Date
Aug 27, 2025
About this record

Access comprehensive regulatory information for Multi-standard nucleic acid detection reagent set for microcrystalline pneumonia pathogens in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 16e3881c4e343bd2a6aa10d28713298a and manufactured by BIOFIRE DIAGNOSTICS, LLC. The authorized representative in Taiwan is BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices